Gail H. Cassell
Gail H. Cassell | |
|---|---|
| Alma mater | University of Alabama at Tuscaloosa University of Alabama at Birmingham |
| Scientific career | |
| Fields | Microbiology, mycoplasma, multidrug-resistant tuberculosis |
| Institutions | University of Alabama at Birmingham Eli Lilly and Company Infectious Disease Research Institute |
| Doctoral advisor | Richard B. Johnston |
Gail Houston Cassell is an American microbiologist whose research focuses on Mycoplasma species and multidrug-resistant tuberculosis. She is vice president of TB drug development at the Infectious Disease Research Institute. In 1994 she was the president of the American Society for Microbiology (ASM).
Life
[edit]Cassell completed a undergraduate degree at the University of Alabama at Tuscaloosa.[1] She earned a M.S. and Ph.D. in microbiology at the University of Alabama at Birmingham (UAB).[1] Her 1973 dissertation was titled Experimental mycoplasma pulmonis infection in pathogen-free mice: pathogensis and immune response. Richard B. Johnston was her doctoral advisor.[2] By 1973, she was married to Ralph Cassell.[2]
She began her research and teaching career at UAB in 1973 as an assistant professor in the department of comparative medicine.[1] She was named Charles H. McCauley professor of microbiology in 1994 and served as chair of the department of microbiology from 1987 to 1997 and as of 2003 is a professor emerita.[1] By 2003, she was also professor in the department of pediatrics and the department of comparative medicine. She was a senior scientist at UAB's center for AIDS research, cystic fibrosis center, and multipurpose arthritis center.[1] Cassell joined Eli Lilly and Company in 1997 as vice president of infectious disease research.[1] In 2002, she was promoted to vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases.[1] She is an elected member of the Institute of Medicine.[1] Cassell became a senior lecturer on global health and social medicine at the Harvard Medical School.[3] She is vice president for TB drug development at the Infectious Disease Research Institute.[3][4]
References
[edit]- ^ a b c d e f g h "Cassell to give FIC global health lecture" (PDF). NIH Record. June 10, 2003. p. 3. Retrieved 2022-10-09.
This article incorporates text from this source, which is in the public domain.
- ^ a b Cassell, Gail Houston (1973). Experimental mycoplasma pulmonis infection in pathogen-free mice: pathogensis and immune response (Ph.D. thesis). University of Alabama at Birmingham.
- ^ a b "Gail H Cassell". ghsm.hms.harvard.edu. 20 December 2019. Retrieved 2022-10-09.
- ^ "Gail H. Cassell, Ph.D." ASM.org. Retrieved 2022-10-09.
This article incorporates public domain material from websites or documents of the National Institutes of Health.External links
[edit]
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
- Living people
- American microbiologists
- American women microbiologists
- 20th-century American biologists
- 21st-century American biologists
- 20th-century American women scientists
- 21st-century American women scientists
- Members of the National Academy of Medicine
- University of Alabama at Birmingham alumni
- University of Alabama alumni
- University of Alabama at Birmingham faculty
- Eli Lilly and Company people
- Tuberculosis researchers
- American medical researchers
- American women medical researchers